The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs
Open accessAbstract
BACKGROUND: People who take analgesic drugs frequently may be at increased risk of end-stage renal disease (ESRD), but the extent of this risk remains unclear. METHODS: We studied 716 patients treated for ESRD and 361 control subjects of similar age from Maryland, Virginia, West Virginia, and Washington, D.C. The study participants were interviewed by telephone about their past use of medications containing acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (NSAIDs). For each analgesic drug, the average use (in pills per year) and the cumulative intake (in pills) were examined for any association with ESRD. RESULTS: Heavier acetaminophen use was associated with an increased risk of ESRD in a dose-dependent fashion. When persons who took an average of 0 to 104 pills per year were used for reference, the odds ratio of ESRD was 1.4 (95 percent confidence interval, 0.8 to 2.4) for those who took 105 to 365 pills per year and 2.1 (95 percent confidence interval, 1.1 to 3.7) for those who took 366 or more pills per year, after adjustment for race, sex, age, and intake of other analgesic drugs. When persons who had taken fewer than 1000 pills containing acetaminophen in their lifetime were used for reference, the odds ratio was 2.0 (95 percent confidence interval, 1.3 to 3.2) for those who had taken 1000 to 4999 pills and 2.4 (95 percent confidence interval, 1.2 to 4.8) for those who had taken 5000 or more pills. Approximately 8 to 10 percent of the overall incidence of ESRD was attributable to acetaminophen use. A cumulative dose of 5000 or more pills containing NSAIDs was also associated with an increased odds of ESRD (odds ratio, 8.8), but the use of aspirin was not. CONCLUSIONS: People who often take acetaminophen or NSAIDs have an increased risk of ESRD, but not those who often take aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Renal damage is also produced by chronic use of paracetamol; in a case-control study involving 1,077 subjects who frequently took paracetamol, a dose-dependent relationship between heavier paracetamol use and an increased risk of end-stage renal disease was demonstrated (160).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [160]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Estimating the population attributable risk for multiple risk factors using case-control data.
BRUZZI, P., GREEN, S. B., BYAR, D. P., BRINTON, L. A., & SCHAIRER, C. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114174 · Cited by 1,214
Best Subsets Logistic Regression
Hosmer, D. W., Jovanovic, B. D., & Lemeshow, S. A. (1989) · Biometrics · doi:10.2307/2531779 · Cited by 1,175
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 977
Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular Disease
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F. R., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329
Analgesic Use and Chronic Renal Disease
Sandler, D. P., Smith, J. C., Weinberg, C. R., Buckalew, V. M., Dennis, V. W., Blythe, W. B., & Burgess, W. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905113201903 · Cited by 254
Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213
Renal Effects of Ibuprofen, Piroxicam, and Sulindac in Patients with Asymptomatic Renal Failure
Whelton, A., Stout, R. L., Spilman, P. S., & Klassen, D. K. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-568 · Cited by 203
An Epidemiologic Study of Abuse of Analgesic Drugs
Dubach, U. C., ROSNER, B. A., & Stürmer, T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240304 · Cited by 123
Regular Analgesic Intake and the Risk of End-Stage Renal Failure
Pommer, W., Bronder, E., Greiser, E. M., Helmert, U., dagger, H. J. J., Klimpel, A., Borner, K., & Molzahn, M. (2008) · American Journal of Nephrology · doi:10.1159/000168002 · Cited by 111
Research works printed but not linked: 1
- Spuhler O, 1953, Z Klin Med, 151, 1
Cited by
Sorted by citations
Items 401–481 of 481
Goyer, R. A., Eknoyan, G., Broe, M. E. D., Buckalew, V. M., Mutti, A., Porter, G. A., Jr., & Morin, J. P. (1997) · Renal Failure · doi:10.3109/08860229709048689 · Cited by 1
Chronic Renal Failure. Initial Assessment, Diagnosis and Therapy
ter Wee, P. M. (2000) · European Urology · doi:10.1159/000052373 · Cited by 1
The Epidemiology of Non-Gastrointestinal Adverse Effects of OTC Analgesics
Jones, J. K., & Miwa, L. J. (1998) · Springer eBooks · doi:10.1007/978-94-011-4878-8_4 · Cited by 1
Some lifestyle-related factors and risk of chronic renal failure : A population-based approach
Ejerblad, E. (2005) · Figshare · Cited by 1
Opinion Piece: Medical Marihuana Reconsidered
Grinspoon, L. (1998) · Addiction Research & Theory · doi:10.3109/16066359809026058 · Cited by 1
Lin, F.-Y., Palmer, B. F., & Henrich, W. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5185-5.00038-9 · Cited by 1
Zibar, L., & Vince, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-10067-3_7 · Cited by 1
Hydrocarbons, silicon-containing compounds and pesticides
D’Haese, P. C., Elseviers, M. M., Yaqoob, M. M., & Broe, M. E. D. (2003) · Springer eBooks · doi:10.1007/1-4020-2586-6_27 · Cited by 1
“Here, besides the development of the socalled analgesic nephropathy identifiable with high accuracy by the visualization of renal papillary necrosis [89], analgesic abuse also seems to hold an increased risk for the development of the other types of renal diseases [ 90 ].”
BackgroundComplementary therapies for osteoarthritis
Long, L. (2001) · Focus on Alternative and Complementary Therapies · doi:10.1211/fact.2001.00085
PREDNOSTI PARACETAMOLA U LIJEČENJU OSOBA S HIPERTONIJOM I ARTROZOM
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2011) · University of Zagreb University Computing Centre (SRCE)
Un nouveau défi : la préservation du capital néphronique
Cittanova, M. L. (2000) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(00)00290-2
Caspi, D., & Segal, R. (2002) · JCR Journal of Clinical Rheumatology · doi:10.1097/00124743-200212000-00002
Du nouveau sur les AINS: découverte de la COX-2 et implications pharmacologiques et cliniques
Borel, S., Bonnabry, P., Desmeules, J. A., & Dayer, P. (1998) · Douleur et Analgésie · doi:10.1007/bf03013286
Calabia, E. R., & Rodríguez, M. A. (2003) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(03)71103-2
Analgesics and 5-aminosalicylic acid
Elseviers, M. M., & Broe, M. E. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-84843-3_17
Medications Impair Kidney Function in Stroke Population—Reply
Ovbiagele, B. I. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.3
A Concept-Wide Association Study of Clinical Notes in Search of New Predictors of Kidney Failure
Singh, K. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Sharma, P., Chaurasiya, R., Arnold, R., Agnihotri, S. K., Saxena, A., & Tiwari, S. (2013)
Beinfield, H., & Korngold, E. (2005)
Pain Management Therapy: The Benefits of Compounded Transdermal Pain
de Carvalho, M. C. T., & Branvold, A. (2014)
Familial Aggregation of Renal Disease in a Population-Based
Lei, H., Perneger, T., Klag, M. J., Whelton, P. K., & Coresh, J. (1998)
Self-citationOxidants, Radicals, Free Radicals, and Other Bad Stuff in Mechanisms of Toxicity
Smith, C. V. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-19096-9_3
Lebov, J. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/says-3m06
Die renale Osteodystrophie - eine Literaturstudie
der Ludwig-Maximilians-Universität, F., & Rambeck, W. A. (2007)
FACTORS ASSOCIATED WITH RENAL INSUFFICIENCY IN TAIWANESE GOUT
Chen, S., & Kamatani, N. (2006) · GOUT AND NUCLEIC ACID METABOLISM · doi:10.6032/gnam1999.30.2_225
Phenacetin or Anything: What Makes or Made Analgesics Nephrotoxic?
Vanholder, R. C. (1998) · Acta Clinica Belgica · doi:10.1080/17843286.1998.11754179
CANZANO, P. (2016) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/canzano-paola_phd2016-01-12
Diogo, L. P., Saitovitch, D., Biehl, M., Bahlis, L. F., O'Keeffe, C. F., Carvalhal, G. F., & Gomes, V. (2008) · DOAJ (DOAJ: Directory of Open Access Journals)
Verma, A., & Sharma, R. L. (2015) · International Journal of Ayurveda and Pharma Research
A Pediatrician's View: Headaches and the Primary Care Pediatrician
Altemeier, W. A. (1995) · Pediatric Annals · doi:10.3928/0090-4481-19950901-04
The effect of acetylsalicylic acid and meloxicamon hematological parameters in rats
Ćupić, V., Pejcic, P., Trailović, D., Prokić, B., Ivanović, S. R., & Ćupić-Miladinović, D. (2015) · Veterinarski glasnik · doi:10.2298/vetgl1506357c
MEDICATIONS IN THE MANAGEMENT OF HEADACHE OF OVER-THE-COUNTER
Sheftell, F. D. (1997)
Clinical Implications of Renal Toxicity
Kang, D.-H. (2013) · CRC Press eBooks · doi:10.1201/b15476-16
Drug-induced chronic tubulointerstitial nephritis
Izzedine, H., & Gueutin, V. (2015) · doi:10.1093/med/9780199592548.003.0087
Acetaminophen - ein COX-Hemmer und die (unangenehmen) Folgen davon
Marko, P. J. (2003) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2003.04927
Risk Factors for Chronic Kidney Disease
Kassem, H. S., & Jaar, B. G. (2019) · doi:10.1093/med/9780190611620.003.0004
Peerapen, P., & Thongboonkerd, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815864-7.00007-6
Acizii graşi cetilaţi îmbunătăţesc funcţia genunchiului la pacienţii cu osteoartrită
Hesslink, R. L., Armstrong, D. W., Sreevatsan, S., & Barathur, R. R. (2002)
Polypharmacy and Frailty in Chronic Kidney Disease
Takeuchi, H., Uchida, H. A., & Wada, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-2365-6_14
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-23251-0.10005-7
Analgesics and 5-aminosalicylic acid
Elseviers, M. M., Schwarz, A., & Broe, M. E. D. (2003) · Springer eBooks · doi:10.1007/1-4020-2586-6_13
Perceived Quality of Life Among Renal Transplant Recipients.
Kamran, F. (2012) · Surrey Research Insight Open Access (The University of Surrey)
Azar, A. T., & Grzegorzewska, A. E. (2012) · Studies in computational intelligence · doi:10.1007/978-3-642-27458-9_1
An overview on Chronic Kidney Disease allied risk factors and complications
Akhila, V., Soumya, S., Eega, S., & Gade, A. R. (2020) · International Journal of Research in Hospital and Clinical Pharmacy · doi:10.33974/ijrhcp.v2i2.189
“4 for those who had taken 5000 or more tablets.[24]”
BackgroundHackenthal, E. (1997) · Springer-Lehrbuch · doi:10.1007/978-3-662-00487-6_14
Pharmacotherapy of Pain in Older Adults
McPherson, M. L. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-668-3_6
Seiler, A. (2005) · Springer eBooks · doi:10.1007/3-211-26646-1_16
Waldvogel, H. H. (2001) · Springer eBooks · doi:10.1007/978-3-642-56710-0_64
Schrör, K. (2016) · Wiley eBooks · doi:10.1002/9783527685059.ch3
(2015) · Elsevier eBooks · doi:10.1016/b978-3-437-23671-6.00006-7
&NA; (1995) · Reactions Weekly · doi:10.2165/00128415-199505330-00011
Anti-inflammatory and antipyretic analgesics and drugs used in gout
Favero, A. D. (1998) · Side effects of drugs annual · doi:10.1016/s0378-6080(98)80013-5
Clinical Implications of Renal Toxicity
Kang, D. (2013) · CRC Press eBooks · doi:10.1201/b15476-14
Efectividad de la acupuntura en el tratamiento del dolor en la artrosis de rodilla
Infante, A. F., Olmos, L. G., Gamarra, A. G., Meis, M. J. M., & Rodríguez, B. M. (2003) · Atención Primaria · doi:10.1016/s0212-6567(03)76315-x
(2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0693-4.50017-7
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00006-8
Terminale nierinsufficiëntie door geneesmiddelen
(1997) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03057018
Huguier, M., & Boëlle, P. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0464-4_19
Hackenthal, E. (2002) · Springer-Lehrbuch · doi:10.1007/978-3-642-56314-0_13
Arend, L. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-443-06966-6.00009-x
Effects of chitosan oligosaccharide and probiotics on chronic kidney disease rats
Anegkamol, W., Dissayabutra, T., Chuaypen, N., & Leelahavanichkul, A. (2022) · doi:10.58837/chula.the.2022.228
Drug Induced Kidney Disease: Epidemiology, Pathophysiology and Management
Ingale, K., Patil, P. H., & Sonar, K. V. (2024) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2024.v84i02.011
CAPÍTULO 9: NEFROTOXICIDAD POR FÁRMACOS
Papaginovic, M., Díez, G., Butto, S., & González, C. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i2sup.792
“…en ERC avanzada que no requirió terapia de reemplazo renal (TRR), se reveló que la exposición acumulativa a paracetamol y aspirina se asoció con un riesgo de ERC; lo mismo se pudo ob-servar en estudios con pacientes con artritis reuma-toide tratados con inhibidores de la COX-2 35,36,37,38,39 .”
BackgroundExploring Public Awareness of Kidney Failure and Its Management in Sialkot, Punjab
Afzal, F., Adnan, S., Batool, Z., Khanum, S., Munsif, A., Shafique, H., Mureed, F., Nadeem, M., & Ayaz, N. (2025) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i4.1708
Awareness Regarding the Role Of Physiotherapy Among Gynecologists
Shah, A., Rafique, N., Rafique, A., Khan, S. A., & Ahmed, S. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i3.1728
Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp
Göbel, H. (2025) · Springer eBooks · doi:10.1007/978-3-662-68873-1_8
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943681
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943675
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943669
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943672
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943678
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943684
Monné, S. B., Urgell, C. V., Sáez, M. J. P., Cunillera, O., Diez, J. M. B., Pascual, J., Lago, C., Ruiz, J. R., Gonzalez, B. S., & Pedrós, R. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943687
Toxicidad cardiovascular y renal de los antiinflamatorios no esteroideos
Alfie, J. (2009) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v29i1.1057
Pujari, R., & Dange, A. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10387-3
“…for humans, several clinical and experimental reports indicate that repeated or prolonged administration of paracetamol, even at near-therapeutic doses, can lead to renal injury, particularly under conditions of sustained exposure, oxidative stress, or compromised renal function [40, 47 , 48].”
Kushner, P. R., & Mende, C. W. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0017
Yaqoob, M. M., D’Haese, P. C., Elseviers, M. M., Broe, M. E. D., & Porter, G. A., Jr. (1998) · Springer eBooks · doi:10.1007/978-94-015-9088-4_29
Metadata
- Authors
- Perneger, T. V., Whelton, P. K., & Klag, M. J.
- Affiliations
- University of Geneva (CH)
- Johns Hopkins University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-12-22
- Volume
- 331
- Issue
- 25
- Pages
- 1675-1679
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2320758398
- Cited by
- 484
- References
- 15
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 18 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 21 · 2019: 19 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 17 · 2014: 17 · 2013: 20 · 2012: 20
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (R03-HS06978-01)
- National Center for Research Resources (5MOIRR00722, RR 00035)
- Topics
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- end-stage renal disease, renal failure, paracetamol, aspirin, nonsteroidal anti-inflammatory drugs, analgesic use, dose-response relationship, attributable risk, drug-induced nephrotoxicity
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Drug Utilization, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Causality, Confidence Intervals, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review